About Johns Hopkins Investigational Drug Service
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Johns Hopkins Investigational Drug Service
During the past decade, Johns Hopkins Investigational Drug Service conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Johns Hopkins Investigational Drug Service
According to Clinical.Site data, the most researched conditions in "Johns Hopkins Investigational Drug Service" are
"Duchenne Muscular Dystrophy" (2 trials), "Anaplastic Astrocytoma" (1 trials), "Anaplastic Ganglioglioma" (1 trials), "Anaplastic Oligodendroglioma" (1 trials) and "Anaplastic Pleomorphic Xanthoastrocytoma" (1 trials). Many other conditions were trialed in "Johns Hopkins Investigational Drug Service" in a lesser frequency.
Clinical Trials Intervention Types at Johns Hopkins Investigational Drug Service
Most popular intervention types in "Johns Hopkins Investigational Drug Service" are "Biological" (3 trials) and "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "PF-06252616" (2 trials), "Antibody Drug Conjugate Chemotherapeutic" (1 trials), "Placebo" (1 trials), "dabrafenib" (1 trials) and "trametinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Johns Hopkins Investigational Drug Service
The vast majority of trials in "Johns Hopkins Investigational Drug Service" are
2 trials for "All" genders and 2 trials for "Male" genders.
Clinical Trials Status at Johns Hopkins Investigational Drug Service
Currently, there are NaN active trials in "Johns Hopkins Investigational Drug Service".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Johns Hopkins Investigational Drug Service,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Johns Hopkins Investigational Drug Service, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".